125 related articles for article (PubMed ID: 16328048)
1. p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effect.
Mitlianga PG; Sioka C; Vartholomatos G; Goussia A; Polyzoidis K; Rao JS; Kyritsis AP
Oncol Rep; 2006 Jan; 15(1):149-53. PubMed ID: 16328048
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma.
Geoerger B; Vassal G; Opolon P; Dirven CM; Morizet J; Laudani L; Grill J; Giaccone G; Vandertop WP; Gerritsen WR; van Beusechem VW
Cancer Res; 2004 Aug; 64(16):5753-9. PubMed ID: 15313916
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
4. AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy.
Idema S; Lamfers ML; van Beusechem VW; Noske DP; Heukelom S; Moeniralm S; Gerritsen WR; Vandertop WP; Dirven CM
J Gene Med; 2007 Dec; 9(12):1046-56. PubMed ID: 17966130
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas.
Shinoura N; Yoshida Y; Asai A; Kirino T; Hamada H
Cancer Gene Ther; 2000 May; 7(5):732-8. PubMed ID: 10830720
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
8. Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
van Beusechem VW; van den Doel PB; Grill J; Pinedo HM; Gerritsen WR
Cancer Res; 2002 Nov; 62(21):6165-71. PubMed ID: 12414643
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma.
Lamfers ML; Idema S; Bosscher L; Heukelom S; Moeniralm S; van der Meulen-Muileman IH; Overmeer RM; van der Valk P; van Beusechem VW; Gerritsen WR; Vandertop WP; Dirven CM
Clin Cancer Res; 2007 Dec; 13(24):7451-8. PubMed ID: 18094429
[TBL] [Abstract][Full Text] [Related]
11. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.
Fueyo J; Gomez-Manzano C; Alemany R; Lee PS; McDonnell TJ; Mitlianga P; Shi YX; Levin VA; Yung WK; Kyritsis AP
Oncogene; 2000 Jan; 19(1):2-12. PubMed ID: 10644974
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of vaccinia virus in glioma model.
Timiryasova TM; Li J; Chen B; Chong D; Langridge WH; Gridley DS; Fodor I
Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
[TBL] [Abstract][Full Text] [Related]
13. Conditionally replicative adenoviral vectors for malignant glioma.
Sonabend AM; Ulasov IV; Lesniak MS
Rev Med Virol; 2006; 16(2):99-115. PubMed ID: 16416455
[TBL] [Abstract][Full Text] [Related]
14. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas.
BenÃtez JA; Arregui L; Vergara P; Segovia J
Cancer Gene Ther; 2007 Oct; 14(10):836-46. PubMed ID: 17599090
[TBL] [Abstract][Full Text] [Related]
15. Potential confounding features in p53 gene therapy of recurrent glioma.
Weil RJ
J Clin Oncol; 2004 Apr; 22(7):1344-5; author reply 1345. PubMed ID: 15051789
[No Abstract] [Full Text] [Related]
16. p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal.
Batista LF; Roos WP; Kaina B; Menck CF
Mol Cancer Res; 2009 Feb; 7(2):237-46. PubMed ID: 19208740
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
[TBL] [Abstract][Full Text] [Related]
18. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
19. Mild hyperthermia plus adenoviral p53 over-expression additively inhibits the viability of human malignant glioma cells.
Nashimoto T; Komata T; Kanzawa T; Aoki H; Endo S; Kon T; Uzuka T; Takahashi H; Kondo S; Tanaka R
Int J Hyperthermia; 2005 Nov; 21(7):615-29. PubMed ID: 16278167
[TBL] [Abstract][Full Text] [Related]
20. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
